activity
20072023
most citedTime-dependent mediators in survival analysis: Modelling direct and indirect effects with the additive hazards model

58 citations · 73 across the 8 of their papers we have counts for

collaborators

8 papers

stat.ME2023

Time-dependent mediators in survival analysis: Graphical representation of causal assumptions

Søren Wengel Mogensen, Odd O. Aalen, Susanne Strohmaier

We study time-dependent mediators in survival analysis using a treatment separation approach due to Didelez [2019] and based on earlier work by Robins and Richardson [2011]. This a…

stat.ME2020★ 58 cited

Time-dependent mediators in survival analysis: Modelling direct and indirect effects with the additive hazards model

Odd O. Aalen, Mats J. Stensrud, Vanessa Didelez +3

We discuss causal mediation analyses for survival data and propose a new approach based on the additive hazards model. The emphasis is on a dynamic point of view, that is, understa…

stat.ME2020★ 1 cited

A hybrid landmark Aalen-Johansen estimator for transition probabilities in partially non-Markov multi-state models

N. Maltzahn, R. Hoff, O. O. Aalen +3

Multi-state models are increasingly being used to model complex epidemiological and clinical outcomes over time. It is common to assume that the models are Markov, but the assumpti…

stat.AP2017★ 12 cited

The surprising implications of familial association in disease risk

Morten Valberg, Mats Julius Stensrud, Odd O. Aalen

Background: A wide range of diseases show some degree of clustering in families; family history is therefore an important aspect for clinicians when making risk predictions. Famili…

stat.ME2016

Estimating the treatment effect on the treated under time-dependent confounding in an application to the Swiss HIV Cohort Study

J. M. Gran, R. Hoff, K. Røysland +3

When comparing time-varying treatments in a non-randomised setting, one must often correct for time-dependent confounders that influence treatment choice over time and that are the…

stat.ME2015

Dynamic path analysis - A useful tool to investigate mediation processes in clinical survival trials

Susanne Strohmaier, Kjetil Røysland, Rune Hoff +3

When it comes to clinical survival trials, regulatory restrictions usually require the application of methods that solely utilize baseline covariates and the intention-to-treat pri…